-
1 Comment
iRhythm Technologies, Inc is currently in a long term downtrend where the price is trading 61.6% below its 200 day moving average.
From a valuation standpoint, the stock is 98.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 15.0.
iRhythm Technologies, Inc's total revenue rose by 33.3% to $79M since the same quarter in the previous year.
Its net income has increased by 44.2% to $-10M since the same quarter in the previous year.
Finally, its free cash flow grew by 132.7% to $5M since the same quarter in the previous year.
Based on the above factors, iRhythm Technologies, Inc gets an overall score of 4/5.
Industry | Medical Devices |
---|---|
Sector | Healthcare |
CurrencyCode | EUR |
Exchange | F |
ISIN | US4500561067 |
Beta | 1.41 |
---|---|
Target Price | 66.4 |
PE Ratio | None |
Dividend Yield | 0.0% |
Market Cap | 3B |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for I25.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024